# Polyethylene Glycol to Improve Sensation Following Digital Nerve Laceration

> **NCT04270019** · PHASE1,PHASE2 · WITHDRAWN · sponsor: **Nova Scotia Health Authority**

## Conditions studied

- Peripheral Nerve Injury
- Nerve Injury

## Interventions

- **DRUG:** Polyethylene Glycol 3350
- **DRUG:** Normal Saline

## Key facts

- **NCT ID:** NCT04270019
- **Lead sponsor:** Nova Scotia Health Authority
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2020-06-26
- **Primary completion:** 2023-09-15
- **Final completion:** 2023-09-15
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** lack of staff, REB closed the file due to expired renewal
- **Last updated:** 2024-01-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04270019

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04270019, "Polyethylene Glycol to Improve Sensation Following Digital Nerve Laceration". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT04270019. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*